CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK, FEMAILE SITES-CORE FUNCTION ACTIVITIES
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK, FEMAILE SITES-CORE FUNCTION ACTIVITIES
批准号:
10897677
负责人:
KATHARINE WHITE
金额:
$0.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-01 至 2024-07-31
关键词:
ClinicalClinical Trials NetworkCommunicationConduct Clinical TrialsContraceptive AgentsContraceptive methodsContractorDevelopmentFutureGoalsMedicalMethodsMissionNational Institute of Child Health and Human DevelopmentObesityPerformanceProgram DevelopmentProtocols documentationRisk ReductionServicesSiteTimeWomanproduct developmentprotocol developmentunintended pregnancyvenous thromboembolism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
There is a demand for new methods of contraception that can provide effective protection against unintended pregnancy as well as reduce the risk of venous thromboembolism (VTE), particularly for obese women. The mission of the Contraceptive Clinical Trials Network (CCTN) is to develop protocols and conduct clinical trials that will assist in product development with the end goal to provide effective and safe contraception for women.
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has a mission to develop safe and effective contraceptives for women, including obese women and women who have medical conditions for which current contraceptive products are contraindicated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CCTN - FEMALE SITES - EVALUATION OF LONG ACTING REVERSIBLE CONTRACEPTIVES
-
批准号:9923500
-
项目类别:
-
资助金额:$34.05万
-
财政年份:2015
-
负责人:KATHARINE WHITE
-
依托单位:
CCTN - FEMALE SITES - EVALUATION OF LONG ACTING REVERSIBLE CONTRACEPTIVES
-
批准号:9152426
-
项目类别:
-
资助金额:$33.78万
-
财政年份:2015
-
负责人:KATHARINE WHITE
-
依托单位:
海外基金